The role of methyl-binding proteins in chromatin organization and epigenome maintenance

Briefings in Functional Genomics

Volumn 11, Issue 3, 2012, Pages 251-264

  Fournier, Alexandra ^a   Sasai, Nobuhiro ^b   Nakao, Mitsuyoshi ^c   Defossez, Pierre Antoine ^a  

^a Université Sorbonne Paris Cité   (France)

^b Global COE Program   (France)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Cancer; DNA methylation recognition; Epigenetic cooperation; Heterochromatin formation and maintenance; Transcriptional repression

Indexed keywords

KAISO LIKE PROTEIN; KAISO PROTEIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; UHRF1 PROTEIN; UNCLASSIFIED DRUG; ZBTB4 PROTEIN;

ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; DEMETHYLATION; DNA METHYLATION; DNA REPAIR; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HETEROCHROMATIN; HUMAN; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

ANIMALS; BINDING SITES; CHROMATIN; CPG ISLANDS; DNA; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENOME; HUMANS;

MAMMALIA;

EID: 84864301890     PISSN: 20412649     EISSN: 20412657     Source Type: Journal    
DOI: 10.1093/bfgp/elr040     Document Type: Article

References (146)

1. Mohn F, Schubeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 2009;25:129-36.
2. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011;25:1010-22.
3. Blackledge NP, Klose R. CpG island chromatin: a platform for gene regulation. Epigenetics 2011;6:147-52.
4. Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005;74:481-514.
5. Damelin M, Bestor TH. Biological functions of DNA methyltransferase 1 require its methyltransferase activity. Mol Cell Biol 2007;27:3891-9.
6. Takebayashi S, Tamura T, Matsuoka C, et al. Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions. Mol Cell Biol 2007;27:8243-58.
7. Stancheva I, Hensey C, Meehan RR. Loss of the maintenance methyltransferase, xDnmt1, induces apoptosis in Xenopus embryos. EmboJ 2001;20:1963-73.
8. Stancheva I, Meehan RR. Transient depletion of xDnmt1 leads to premature gene activation in Xenopus embryos. Genes Dev 2000;14:313-27.
9. Anderson RM, Bosch JA, Goll MG, et al. Loss of Dnmt1 catalytic activity reveals multiple roles for DNA methylation during pancreas development and regeneration. Dev Biol 2009;334:213-23.
10. Tittle RK, Sze R, Ng A, et al. Uhrf1 and Dnmt1 are required for development and maintenance of the zebrafish lens. Dev Biol 2011;350:50-63.
11. Tsumura A, Hayakawa T, Kumaki Y, et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 2006;11:805-14.
12. Sakaue M, Ohta H, Kumaki Y, et al. DNA methylation is dispensable for the growth and survival of the extraembryonic lineages. Curr Biol 2011;20:1452-7.
13. Ciccone DN, Su H, Hevi S, et al. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 2009;461:415-8.
14. Esteve PO, Chin HG, Smallwood A, et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 2006;20: 3089-103.
15. Jackson JP, Lindroth AM, Cao X, et al. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 2002;416:556-60.
16. Lehnertz B, Ueda Y, Derijck AA, et al. Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 2003;13:1192-200.
17. Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 2001;414: 277-83.
18. Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2006;439:871-4.
19. Wang J, Hevi S, Kurash JK, et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 2009;41:125-9.
20. Meissner A, Mikkelsen TS, Gu H, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008;454:766-70.
21. Zilberman D, Coleman-Derr D, Ballinger T, et al. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. Nature 2008;456:125-9.
22. Ooi SK, Qiu C, Bernstein E, et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007;448:714-7.
23. Otani J, Nankumo T, Arita K, et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBORep 2009;10:1235-41.
24. Hendrich B, Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. TrendsGenet 2003;19:269-77.
25. Laget S, Joulie M, Le Masson F, et al. The Human Proteins MBD5 and MBD6 Associate with Heterochromatin but They Do Not Bind Methylated DNA. PLoS One 2010;5(8):e11982.
26. Roloff TC, Ropers HH, Nuber UA. Comparative study of methyl-CpG-binding domain proteins. BMC Genomics 2003;4:1.
27. Amir RE, Van den Veyver IB, Wan M, et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-8.
28. Collins AL, Levenson JM, Vilaythong AP, et al. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. HumanMol Genet 2004;13:2679-89.
29. Guy J, Hendrich B, Holmes M, et al. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 2001;27:322-6.
30. Chen RZ, Akbarian S, Tudor M, et al. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 2001;27:327-31.
31. Daniel JM, Reynolds AB. The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain zinc finger transcription factor. Mol Cell Biol 1999;19:3614-23.
32. Prokhortchouk A, Hendrich B, Jorgensen H, et al. The p120 catenin partner Kaiso is a DNA methylationdependent transcriptional repressor. Genes Dev 2001;15: 1613-8.
33. Daniel JM, Spring CM, Crawford HC, et al. The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides. Nucleic Acids Res 2002;30: 2911-9.
34. Sasai N, Nakao M, Defossez PA. Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res 2010;38:5015-22.
35. Perez-Torrado R, Yamada D, Defossez PA. Born to bind: the BTB protein-protein interaction domain. Bioessays 2006;28:1194-202.
36. Ruzov A, Savitskaya E, Hackett JA, et al. The non-methylated DNA-binding function of Kaiso is not required in early Xenopus laevis development. Development 2009;136:729-38.
37. Ruzov A, Dunican DS, Prokhortchouk A, et al. Kaiso is a genome-wide repressor of transcription that is essential for amphibian development. Development 2004;131: 6185-94.
38. Stancheva I, El-Maarri O, Walter J, et al. DNA methylation at promoter regions regulates the timing of gene activation in Xenopus laevis embryos. Dev Biol 2002;243:155-65.
39. Soubry A, Staes K, Parthoens E, et al. The transcriptional repressor Kaiso localizes at the mitotic spindle and is a constituent of the pericentriolar material. PLoS One 2011;5: e9203.
40. Filion GJ, Zhenilo S, Salozhin S, et al. A family of human zinc finger proteins that bind methylated DNA and repress transcription. Mol Cell Biol 2006;26:169-81.
41. Sasai N, Defossez PA. Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes. Int JDevBiol 2009;53:323-34.
42. Costoya JA. Functional analysis of the role of POK transcriptional repressors. Brief Funct Genomic Proteomic 2007;6: 8-18.
43. Sasai N, Matsuda E, Sarashina E, et al. Identification of a novel BTB-zinc finger transcriptional repressor, CIBZ, that interacts with CtBP corepressor. Genes Cells 2005;10: 871-85.
44. Bartke T, Vermeulen M, Xhemalce B, et al. Nucleosomeinteracting proteins regulated by DNA and histone methylation. Cell 2010;143:470-84.
45. Hopfner R, Mousli M, Jeltsch JM, et al. ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression. Cancer Res 2000;60: 121-8.
46. Unoki M, Nishidate T, Nakamura Y. ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 2004;23:7601-10.
47. Hashimoto H, Horton JR, Zhang X, et al. UHRF1, a modular multi-domain protein, regulates replicationcoupled crosstalk between DNA methylation and histone modifications. Epigenetics 2009;4:8-14.
48. Karagianni P, Amazit L, Qin J, et al. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. MolCellBiol 2008;28: 705-17.
49. Papait R, Pistore C, Grazini U, et al. The PHD domain of Np95 (mUHRF1) is involved in large-scale reorganization of pericentromeric heterochromatin. Mol Biol Cell 2008;19: 3554-63.
50. Rottach A, Frauer C, Pichler G, et al. The multi-domain protein Np95 connects DNA methylation and histone modification. Nucleic Acids Res 2010;38:1796-804.
51. Sharif J, Muto M, Takebayashi S, et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007;450:908-12.
52. Arima Y, Hirota T, Bronner C, et al. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 2004;9: 131-42.
53. Bonapace IM, Latella L, Papait R, etal. Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry. J Cell Biol 2002;157: 909-14.
54. Jeanblanc M, Mousli M, Hopfner R, et al. The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene 2005;24:7337-45.
55. Muto M, Kanari Y, Kubo E, et al. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J BiolChem 2002;277:34549-55.
56. Papait R, Pistore C, Negri D, et al. Np95 is implicated in pericentromeric heterochromatin replication and in major satellite silencing. Mol Biol Cell 2007;18:1098-106.
57. Bostick M, Kim JK, Esteve PO, etal. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007;317:1760-4.
58. Bronner C, Achour M, Arima Y, et al. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther 2007;115:419-34.
59. Pichler G, Wolf P, Schmidt CS, et al. Cooperative DNA and histone binding by Uhrf2 links the two major repressive epigenetic pathways. JCell Biochem 2011;112:2585-93.
60. Mori T, Li Y, Hata H, et al. NIRF, a novel RING finger protein, is involved in cell-cycle regulation. BiochemBiophys Res Commun 2002;296:530-6.
61. Woo HR, Dittmer TA, Richards EJ. Three SRA-domain methylcytosine-binding proteins cooperate to maintain global CpG methylation and epigenetic silencing in Arabidopsis. PLoS Genet 2008;4:e1000156.
62. Feng S, Cokus SJ, Zhang X, et al. Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad SciUSA 2010;107:8689-94.
63. Laurent L, Wong E, Li G, et al. Dynamic changes in the human methylome during differentiation. GenomeRes 2010; 20:320-31.
64. Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009;462(7271):315-22.
65. Ramsahoye BH, Biniszkiewicz D, Lyko F, et al. Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. Proc Natl Acad Sci USA 2000;97:5237-42.
66. Johnson LM, Bostick M, Zhang X, et al. The SRA methyl-cytosine-binding domain links DNA and histone methylation. Curr Biol 2007;17:379-84.
67. Yoon HG, Chan DW, Reynolds AB, et al. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell 2003;12: 723-34.
68. Shi Y, Sawada J, Sui G, et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003;422:735-8.
69. Weber A, Marquardt J, Elzi D, et al. Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation. EmboJ 2008;27:1563-74.
70. Kim K, Chadalapaka G, Lee SO, et al. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer. Oncogene 2011; doi: 10.1038/ onc.2011.296. [Epub ahead of print].
71. Hu L, Li Z, Wang P, et al. Crystal structure of PHD domain of UHRF1 and insights into recognition of unmodified histone H3 arginine residue 2. Cell Res 2011; 21:1374-8.
72. Rajakumara E, Wang Z, Ma H, et al. PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression. Mol Cell 2011;43: 275-84.
73. Wang C, Shen J, Yang Z, et al. Structural basis for site-specific reading of unmodified R2 of histone H3 tail by UHRF1 PHD finger. Cell Res 2011;21:1379-82.
74. Chahrour M, Jung SY, Shaw C, et al. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 2008;320:1224-9.
75. Yasui DH, Peddada S, Bieda MC, et al. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci USA 2007;104:19416-21.
76. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 1998;17: 4905-8.
77. Klose RJ, Sarraf SA, Schmiedeberg L, et al. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Mol Cell 2005;19: 667-78.
78. Nikitina T, Ghosh RP, Horowitz-Scherer RA, et al. MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome. J Biol Chem 2007;282:28237-45.
79. Ishibashi T, Thambirajah AA, Ausio J. MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation. FEBS Lett 2008;582:1157-62.
80. Ghosh RP, Horowitz-Scherer RA, Nikitina T, et al. MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites. Mol Cell Biol 2010;30:4656-70.
81. Skene PJ, Illingworth RS, Webb S, et al. Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 2010;37:457-68.
82. Tudor M, Akbarian S, Chen RZ, et al. Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci USA 2002;99:15536-41.
83. Klose RJ, Bird AP. MeCP2 behaves as an elongated monomer that does not stably associate with the Sin3a chromatin remodeling complex. J Biol Chem 2004;279: 46490-6.
84. Guy J, Cheval H, Selfridge J, et al. The role of MeCP2 in the brain. Annu Rev CellDev Biol 2010;27:631-52.
85. De La Fuente R, Baumann C, Viveiros MM. Role of ATRX in chromatin structure and function: implications for chromosome instability and human disease. Reproduction 2011;142:221-34.
86. Nan X, Hou J, Maclean A, et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad SciUSA 2007;104:2709-14.
87. Kernohan KD, Jiang Y, Tremblay DC, et al. ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain. DevCell 2010;18: 191-202.
88. Phillips JE, Corces VG. CTCF: master weaver of the genome. Cell 2009;137:1194-211.
89. Agarwal N, Becker A, Jost KL, et al. MeCP2 Rett mutations affect large scale chromatin organization. Hum Mol Genet 2011;20(21):4187-95.
90. Horike S, Cai S, Miyano M, et al. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet 2005;37:31-40.
91. Tiwari VK, McGarvey KM, Licchesi JD, etal. PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biol 2008;6:2911-27.
92. Hakim O, Sung MH, Hager GL. 3D shortcuts to gene regulation. Curr Opin Cell Biol 2010;22:305-13.
93. Nady N, Lemak A, Walker JR, et al. Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein. J Biol Chem 2011;286:24300-11.
94. Citterio E, Papait R, Nicassio F, et al. Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol 2004;24:2526-35.
95. Choi ES, Kim HS, Jang YK, et al. Two ubiquitinconjugating enzymes, Rhp6 and UbcX, regulate heterochromatin silencing in Schizosaccharomyces pombe. Mol Cell Biol 2002;22:8366-74.
96. Horn PJ, Peterson CL. Heterochromatin assembly: a new twist on an old model. Chromosome Res 2006;14:83-94.
97. Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009;10: 192-206.
98. Reese BE, Bachman KE, Baylin SB, et al. The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1. MolCellBiol 2003;23:3226-36.
99. Sarraf SA, Stancheva I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 2004;15:595-605.
100. Karimi MM, Goyal P, Maksakova IA, et al. DNA methylation and SETDB1/H3K9me3 regulate predominantly distinct sets of genes, retroelements, and chimeric transcripts in mESCs. Cell Stem Cell 2011;8:676-87.
101. Fujita N, Watanabe S, Ichimura T, etal. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 2003;278:24132-8.
102. Sakamoto Y, Watanabe S, Ichimura T, et al. Overlapping roles of the methylated DNA-binding protein MBD1 and polycomb group proteins in transcriptional repression of HOXA genes and heterochromatin foci formation. J Biol Chem 2007;282:16391-400.
103. Tatematsu KI, Yamazaki T, Ishikawa F. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Genes Cells 2000;5:677-88.
104. Kimura H, Shiota K. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J BiolChem 2003;278:4806-12.
105. Uchimura Y, Ichimura T, Uwada J, et al. Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J Biol Chem 2006;281: 23180-90.
106. Lyst MJ, Nan X, Stancheva I. Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins. EMBOJ 2006;25:5317-28.
107. Uwada J, Tanaka N, Yamaguchi Y, et al. The p150 subunit of CAF-1 causes association of SUMO2/3 with the DNA replication foci. Biochem Biophys Res Commun 2010;391: 407-13.
108. Ivanov AV, Peng H, Yurchenko V, et al. PHD domainmediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 2007;28:823-37.
109. Yeap LS, Hayashi K, Surani MA. ERG-associated protein with SET domain (ESET)-Oct4 interaction regulates pluripotency and represses the trophectoderm lineage. Epigenet Chromatin 2009;2:12.
110. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat RevMol Cell Biol 2010;11:861-71.
111. Frauer C, Leonhardt H. Twists and turns of DNA methylation. ProcNatl Acad SciUSA 2011;108:8919-20. 112.
112. Ooi SK, Bestor TH. Cytosine methylation: remaining faithful. Curr Biol 2008;18:R174-6.
113. Avvakumov GV, Walker JR, Xue S, et al. Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 2008;455:822-5.
114. Kim JK, Esteve PO, Jacobsen SE, et al. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res 2009;37:493-505.
115. Uemura T, Kubo E, Kanari Y, et al. Temporal and spatial localization of novel nuclear protein NP95 in mitotic and meiotic cells. Cell Struct Funct 2000;25:149-59.
116. Achour M, Jacq X, Ronde P, et al. The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression. Oncogene 2008;27:2187-97.
117. Arita K, Ariyoshi M, Tochio H, et al. Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 2008;455:818-21.
118. Hashimoto H, Horton JR, Zhang X, et al. The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 2008;455:826-9.
119. Qian C, Li S, Jakoncic J, etal. Structure and hemimethylated CpG binding of the SRA domain from human UHRF1. J Biol Chem 2008;283:34490-4.
120. Bronner C, Fuhrmann G, Chedin FL, et al. UHRF1 links the histone code and DNA methylation to ensure faithful epigenetic memory inheritance. Genet Epigenet 2011;2009: 29-36.
121. Jeltsch A. Reading and writing DNA methylation. Nat StructMol Biol 2008;15:1003-4.
122. Bronner C. Control of DNMT1 abundance in epigenetic inheritance by acetylation, ubiquitylation, and the histone code. Sci Signal 2011;4:pe3.
123. Du Z, Song J, Wang Y, et al. DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylationdriven ubiquitination. Sci Signal 2011;3:ra80.
124. Qin W, Leonhardt H, Spada F. Usp7 and Uhrf1 control ubiquitination and stability of the maintenance DNA methyltransferase Dnmt1. JCellBiochem 2011;112:439-44.
125. Hervouet E, Lalier L, Debien E, etal. Disruption of Dnmt1/ PCNA/UHRF1 interactions promotes tumorigenesis from human and mice glial cells. PLoS One 2011;5:e11333.
126. Peng JC, Karpen GH. Epigenetic regulation of heterochromatic DNA stability. Curr Opin GenetDev 2008;18:204-11.
127. Muotri AR, Marchetto MC, Coufal NG, et al. L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010;468:443-6.
128. Zhao X, Ueba T, Christie BR, et al. Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci USA 2003;100:6777-82.
129. Watanabe S, Ichimura T, Fujita N, et al. Methylated DNA-binding domain 1 and methylpurine-DNA glycosylase link transcriptional repression and DNA repair in chromatin. Proc Natl Acad Sci USA 2003;100: 12859-64.
130. Hendrich B, Hardeland U, Ng HH, et al. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999;401:301-4.
131. Rai K, Huggins IJ, James SR, et al. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008;135:1201-12.
132. Kim MS, Kondo T, Takada I, et al. DNA demethylation in hormone-induced transcriptional derepression. Nature 2009; 461:1007-12.
133. Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat RevMol Cell Biol 2010;11:607-20.
134. Joulie M, Miotto B, Defossez PA. Mammalian methylbinding proteins: what might they do? Bioessays 2010;32: 1025-32.
135. Quenneville S, Verde G, Corsinotti A, et al. In embryonic stem cells, ZFP57/KAP1 recognize a methylated hexanucleotide to affect chromatin and DNA methylation of imprinting control regions. Mol Cell 2011;44:361-72.
136. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009;324:929-30.
137. Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009;324:930-5.
138. Wu H, Zhang Y. Tet1 and 5-hydroxymethylation: A genome-wide view in mouse embryonic stem cells. Cell Cycle 2011;10:2428-36.
139. Huang Y, Pastor WA, Shen Y, et al. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010;5:e8888.
140. Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res 2010;38(11):e125.
141. Nestor C, Ruzov A, Meehan R, etal. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques 2010;48:317-9.
142. Szwagierczak A, Brachmann A, Schmidt CS, et al. Characterization of PvuRts1I endonuclease as a tool to investigate genomic 5-hydroxymethylcytosine. Nucleic Acids Res 2011;39:5149-56.
143. Szwagierczak A, Bultmann S, Schmidt CS, et al. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 2011;38:e181.
144. Valinluck V, Tsai HH, Rogstad DK, etal. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004;32:4100-8.
145. Frauer C, Hoffmann T, Bultmann S, et al. Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain. PLoS One 2011;6:e21306.
146. Guo JU, Su Y, Zhong C, et al. Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond. Cell Cycle 2011;10:2662-8.